MedTrace Logo

Evaluation of a Novel Class of Objective Myofascial Pain Assessments

NCT05793086 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2026-01-30

No results posted yet for this study

Summary

This is an observational study that is intended to determine the capacity of three technologies to serve as diagnostic biomarkers for myofascial pain syndrome. Investigators will seek patients with myofasical pain syndrome as well as healthy subjects for this study. Electrical impedance myography (EIM), myofiber threshold tracking (TT) excitability testing, and ultrasound with shear wave elastography (SWE) measurements will be obtained from the trapezius muscle (the muscle that extends over the back of the neck and shoulders). These measurements will be repeated within 2-5 days to assess repeatability of these methods.

Conditions

  • Myofascial Pain
  • Trigger Point Pain, Myofascial

Interventions

DIAGNOSTIC_TEST

Ultrasound

Using shear wave elastography and gray scale analysis of ultrasound.

DIAGNOSTIC_TEST

Electrical impedance myography

Measurement of localized bioimpedance of muscle

DIAGNOSTIC_TEST

Excitability testing

Electrical studies of myofiber excitability

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-27
Primary Completion
2025-05-01
Completion
2026-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05793086 on ClinicalTrials.gov